Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Khong

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|August 24, 2011
Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myelomaTiffany Khong, Andrew Spencer
Haematologica|April 30, 2008
The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myelomaTiffany Khong, Janelle Sharkey, Andrew Spencer
Blood|October 13, 2006
PKC412 demonstrates JNK-dependent activity against human multiple myeloma cellsJanelle Sharkey, Tiffany Khong, Andrew Spencer
Journal of Clinical Medicine|December 11, 2022
Extracellular Vesicles and Their Roles in the Tumor Immune MicroenvironmentAntonia Reale, Tiffany Khong, Andrew Spencer
Frontiers in Oncology|September 13, 2021
Translational Potential of RNA Derived From Extracellular Vesicles in Multiple MyelomaAntonia Reale, Tiffany Khong, Sridurga Mithraprabhu, et al.
Investigational New Drugs|December 4, 2010
Deactylase inhibition in myeloproliferative neoplasmsSridurga Mithraprabhu, George Grigoriadis, Tiffany Khong, et al.
Investigational New Drugs|November 13, 2009
CYT997 causes apoptosis in human multiple myelomaKatherine Monaghan, Tiffany Khong, Gregg Smith, et al.
British Journal of Haematology|May 23, 2013
Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDACSridurga Mithraprabhu, Tiffany Khong, Simon S Jones, et al.
Epigenetics|December 9, 2014
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myelomaSridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
International Journal of Molecular Sciences|June 26, 2018
Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple MyelomaSridurga Mithraprabhu, Shreerang Sirdesai, Maoshan Chen, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 24, 2011
Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myelomaTiffany Khong, Andrew Spencer
Haematologica|April 30, 2008
The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myelomaTiffany Khong, Janelle Sharkey, Andrew Spencer
Blood|October 13, 2006
PKC412 demonstrates JNK-dependent activity against human multiple myeloma cellsJanelle Sharkey, Tiffany Khong, Andrew Spencer
Journal of Clinical Medicine|December 11, 2022
Extracellular Vesicles and Their Roles in the Tumor Immune MicroenvironmentAntonia Reale, Tiffany Khong, Andrew Spencer
Frontiers in Oncology|September 13, 2021
Translational Potential of RNA Derived From Extracellular Vesicles in Multiple MyelomaAntonia Reale, Tiffany Khong, Sridurga Mithraprabhu, et al.
Investigational New Drugs|December 4, 2010
Deactylase inhibition in myeloproliferative neoplasmsSridurga Mithraprabhu, George Grigoriadis, Tiffany Khong, et al.
Investigational New Drugs|November 13, 2009
CYT997 causes apoptosis in human multiple myelomaKatherine Monaghan, Tiffany Khong, Gregg Smith, et al.
British Journal of Haematology|May 23, 2013
Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDACSridurga Mithraprabhu, Tiffany Khong, Simon S Jones, et al.
Epigenetics|December 9, 2014
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myelomaSridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
International Journal of Molecular Sciences|June 26, 2018
Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple MyelomaSridurga Mithraprabhu, Shreerang Sirdesai, Maoshan Chen, et al.
Pageof 5